Pearls in Writing · From the Podcast

Wellbutrin vs Trintellix — Key Takeaways: Emotional Blunting, Dopamine Augmentation, and Serotonin Fine-Tuning

When an SSRI lifts the depression but leaves joy, motivation, and emotional range flat, the answer depends on what the flatness actually is — residual depression, or SSRI-induced emotional blunting. In this episode NP Z works through the two classic next moves: augment with Wellbutrin (bupropion) for a dopamine kick, or switch to Trintellix (vortioxetine) to fine-tune serotonin instead — and the whole argument fits on a single index card.

🎧 From the episode: Wellbutrin (Bupropion) vs Trintellix (Vortioxetine) After SSRI Failure

Pearls and Prep pearl

📇 The Index Card — Key Takeaways

Wellbutrin (Bupropion) vs Trintellix (Vortioxetine)

The scenario — better, but flat. The SSRI has done real work: the patient is less tearful, less reactive, and ruminating less. But joy, motivation, drive, and emotional range are still muted — not sad anymore, just numb. NP Z's warning: that picture is often a mix of leftover depression and serotonergic blunting, and each half wants a different move.

  1. Blunting lives in the salience network. SSRIs can quiet the circuitry that tags things as emotionally important — amygdala, insula, anterior cingulate, ventral striatum — and imaging discussed in the episode shows a reduced neural response to both aversive and rewarding cues. That is why the bad feelings soften and the good ones go with them. Ask about joy, motivation, and emotional range, not just sadness scores, or you will misread blunting as residual depression.
  2. Don't scrap a winning SSRI. First, inventory exactly what the serotonergic drug fixed — the tearfulness, reactivity, and rumination it quieted are real wins. Just lowering the dose to ease blunting can also undercut the antidepressant response. If the SSRI is carrying the core syndrome, the episode's usual move is to augment around the blunting, not throw the baby out with the bathwater.
  3. Wellbutrin is the dopamine pivot. Bupropion is an NDRI — it blocks norepinephrine and dopamine reuptake and leaves serotonin alone — so it counters the serotonergic brake on dopamine in reward and motivation circuits. That is why an SSRI plus Wellbutrin pair so well, in NP Z's phrase, like wine and cheese: two transmitters, two different circuits. Dose it in the morning; it is activating.
  4. The ideal Wellbutrin patient is sluggish. Low energy and low motivation, struggling with basic tasks and self-care — plus the practical bonuses: it does not carry the serotonergic sexual side-effect burden, it is weight-neutral (some patients lose a little), it can help with smoking cessation, and it may help subthreshold ADHD-type features. Wellbutrin XL is also FDA-approved to prevent seasonal affective disorder episodes — started before the patient's vulnerable season.
  5. Wellbutrin's hard stops: seizures and eating disorders. The seizure risk is dose-related, and the FDA label contraindicates bupropion with a seizure disorder and with current or prior anorexia or bulimia. Check those two boxes before the dopamine pitch, every time.
  6. Trintellix fine-tunes serotonin instead of just raising it. Vortioxetine is a multimodal serotonergic drug — not an antipsychotic: it blocks the serotonin transporter like an SSRI, then directly tunes receptor subtypes on top — 5-HT1A agonist, 5-HT1B partial agonist, and 5-HT3 antagonist, among others. Blocking 5-HT3 on GABA interneurons (the brain's braking cells) releases dopamine, norepinephrine, acetylcholine, histamine, and glutamate downstream — a more activating profile with, in the episode's framing, less blunting and a pro-cognitive signal.
  7. Trintellix's lane: cognition, with a nausea tax. Its only FDA indication is major depressive disorder in adults — not anxiety disorders — and its strongest data are for cognitive dysfunction in depression: brain fog, slow processing, poor concentration. Reach for it when the patient still needs serotonin but cannot tolerate SSRI blunting or sexual effects (sexual dysfunction risk is comparatively favorable at lower doses and rises with dose). Expect dose-related nausea — the label's other most common effects are constipation and vomiting (dry mouth and diarrhea are also reported); taking it with food may help — reduce the dose by half with strong CYP2D6 inhibitors, and cap it at 10 mg/day in known CYP2D6 poor metabolizers, per the label — and expect prior authorizations for the brand-name cost.

The call when the SSRI wins but flattens: augment with Wellbutrin when the SSRI is carrying real wins and the missing piece is drive, energy, and reward. Switch to Trintellix when the patient still needs the serotonin lane — but needs it fine-tuned for cognition, blunting, and sexual tolerability instead.

📖 Sources & further reading

  • FDA Prescribing Information: Wellbutrin XL (bupropion) — DailyMed.
  • FDA Prescribing Information: Trintellix (vortioxetine) — DailyMed.
  • U.S. Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. 2022 — PubMed.
  • Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for the Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024 — PubMed.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.

New here? Start with the free door: join Pearls and Prep on Patreon free and get the 50 High-Yield Pearls study guide, or go straight to the topic-labeled collections built from the full episode library.

Ready to feel ready for your first patient? Boss Pearl members unlock the full clinical library — every psychopharm deep dive, the Case Crunch challenges, and the 100 Interview Tips eBook — the bridge from knowing psychiatry to walking in confident.

Join Boss Pearl — $20/mo

⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship.

Keep studying: All episodes on depression → · All psychopharmacology episodes →

Start free — get the 50 Pearls study guide when you join Patreon free.Join Free